bioRxiv · 10.1101/2020.03.21.001552
Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson's disease
Abstract
We performed transcriptome analysis using RNA sequencing on substantia nigra pars compacta (SNpc) from mice after acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment and Parkinsons disease (PD) patients. Acute and chronic exposure to MPTP resulted in decreased expression of genes involved in sodium channel regulation. However, upregulation of pro-inflammatory pathways was seen after single dose but not after chronic MPTP treatment. Dopamine biosynthesis and synaptic vesicle recycling pathways were downregulated in PD patients and after chronic MPTP treatment in mice. Genes essential for midbrain development and determination of dopaminergic phenotype such as, LMX1B, FOXA1, RSPO2, KLHL1, EBF3, PITX3, RGS4, ALDH1A1, RET, FOXA2, EN1, DLK1, GFRA1, LMX1A, NR4A2, GAP43, SNCA, PBX1, and GRB10 were downregulated in human PD and overexpression of LMX1B rescued MPP+ induced death in SH-SY5Y neurons. Downregulation of gene ensemble involved in development and differentiation of dopaminergic neurons indicate their critical involvement in pathogenesis and progression of human PD.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Verma, A., Hirsch, E. C., Ravindranath, V.. 2020-03-24. Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson's disease. https://doi.org/10.1101/2020.03.21.001552
Cite the original work for its findings. Save a collection to share your selection of sources.